Copertina

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Wu Tao, Yu Xufeng, Chen Xianmei, Qu Mengrou, Wang Jieqiong, Qiao Mingqi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
di: Tingting Zhang, et al.
Pubblicazione: (2026)

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
di: Mei Liu, et al.
Pubblicazione: (2024)

The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
di: Xiao Cheng, et al.
Pubblicazione: (2025)

Potential Mechanism of Qiju Dihuang Pill in Treating Primary Sjogren's Syndrome Revealed by Network Pharmacology and Experimental Verification
di: Huiying Wang, et al.
Pubblicazione: (2025)

Promotion Effect of Catalpol on Angiogenesis and Potential Mechanisms: A Research Based on Network Pharmacology
di: Jin‐rong Ni, et al.
Pubblicazione: (2024)

Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
di: Jian Guo, et al.
Pubblicazione: (2024)

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression
di: Fangzhi Ye, et al.
Pubblicazione: (2025)

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity
di: Ruoshuang Liu, et al.
Pubblicazione: (2025)

Network Pharmacology‐Based Analysis and In Vitro Experiments Validation Reveal Tormentic Acid Induces Apoptosis via PI3K / AKT / HSP90 Pathway in HepG2 Cells
di: Jingyang Lu, et al.
Pubblicazione: (2026)

Network Pharmacology Integrated Experimental Validation Uncover Quercetin as the Key Ingredient of Hedyotis diffusa Anti‐BRCA
di: Queting Chen, et al.
Pubblicazione: (2025)

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells
di: Burak Kuzu, et al.
Pubblicazione: (2025)

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity
di: Hsu‐Feng Liu, et al.
Pubblicazione: (2024)

Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
di: Wen‐Shuang Hou, et al.
Pubblicazione: (2025)

From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting LOXL2 in Breast Cancer
di: Sandra Ferreira, et al.
Pubblicazione: (2026)

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling
di: Zhenou Sun, et al.
Pubblicazione: (2025)

Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile
di: Ayse Mine Yilmaz, et al.
Pubblicazione: (2025)

Anti‐metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes
di: Nur Sena Sivri, et al.
Pubblicazione: (2024)

Anti‐Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells
di: Esraa A. Aidy, et al.
Pubblicazione: (2026)

Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
di: Mohamed El Oirdi
Pubblicazione: (2024)

Correction to Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
Pubblicazione: (2024)

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Investigation of the Inhibitory Effects and Underlying Mechanisms of Vitexin Derivatives Targeting CDK1 in HCT Colorectal Cancer Cells
di: Ying Zhao, et al.
Pubblicazione: (2026)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

Pyrazoline–Imidazopyridine Hybrids as Beclin‐1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer
di: Rashmi Shivakumar, et al.
Pubblicazione: (2026)

Spalt‐Like Transcription Factor 4 Mediates Fatty Acid Oxidation to Foster 5‐Fluorouracil Resistance in Gastric Cancer Cells
di: Yong Zhu, et al.
Pubblicazione: (2025)

Prediction of Breast Cancer Lymph Node Metastasis by a Nomogram Model Integrating Pathomics, Radiomics, and Immunoscore
di: Tian Xu, et al.
Pubblicazione: (2026)

99mTc‐HYNIC PEGylated Peptide Probe Targeting HER2‐Expression in Breast Cancer
di: Sushree Arpitabala Yadav, et al.
Pubblicazione: (2025)

The Potent Antioxidant 3,5‐Dihydroxy‐4‐Methoxybenzyl Alcohol Reveals Anticancer Activity by Targeting Several Signaling Pathways in Bone Metastatic Human Breast Cancer MDA‐MB‐231 Cells
di: Masayoshi Yamaguchi, et al.
Pubblicazione: (2025)

Selective Antiproliferative and Apoptotic Effects of 2,6‐Diketopiperazines on MDA‐MB‐231 Triple‐Negative Breast Cancer
di: Flor Paulina Garrido González, et al.
Pubblicazione: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Antioxidant and Amylase, Glucosidase, and Tyrosinase Enzymes Inhibitory Potential of Genistein and 11‐α‐Hydroxyerysotrine Supported by In Silico and Network Pharmacology Approaches
di: Nouran M. Fahmy, et al.
Pubblicazione: (2025)

Platinum‐Based Chemotherapeutics in the Modern Era: From Classical DNA ‐Targeting Mechanisms to Next‐Generation Innovations in Cancer Therapy
di: Mohammad Bagher Shahsavani, et al.
Pubblicazione: (2025)

Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis
di: Yun‐Yi Chen, et al.
Pubblicazione: (2025)

Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
di: Ha Vy Thi Vo, et al.
Pubblicazione: (2025)

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
di: Ze‐Bo Jiang, et al.
Pubblicazione: (2025)

Curculigoside Induces Ferroptosis in Non‐Small Cell Lung Cancer Cells Through a Mechanism Involving Wilms' Tumor 1‐Associating Protein‐Mediated m6A Modification of GTP Cyclohydrolase 1
di: Lizheng Lv, et al.
Pubblicazione: (2026)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
di: Ivana Kuzminac, et al.
Pubblicazione: (2026)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
di: Jingting Zeng, et al.
Pubblicazione: (2025)

Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
di: Neha Sharma, et al.
Pubblicazione: (2024)

Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3/HIF‐1α Signaling
di: Lichao Ji, et al.
Pubblicazione: (2025)